Application of polydatin in preparation of pharmaceuticals for preventing and treating chronic glomerular diseases
A technology for glomerular diseases and polydipside, which is applied in the application field of polydipside in the preparation of drugs for the prevention and treatment of chronic glomerular diseases, can solve the problems of obvious side effects and limited improvement effect, and achieves clear regulation effect and clear composition. , the effect of good safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Example Embodiment
[0029] Example 1: Polydatin improves the treatment of glomerulopathy in fructose model rats.
[0030] Experimental animals: SD rats, 200-220 grams, male.
[0031] Drug preparation: use polydatin content of 20mg / tablet for the prevention or treatment of glomerular diseases, ultrasonically dispersed in normal saline, for intragastric administration, the dosage is 7.5mg / kg.
[0032] Experimental instruments: high-speed refrigerated centrifuge, tissue slicer, microplate reader, spectrophotometer, optical microscope, transmission electron microscope, etc.
[0033] Experimental model: Fructose rat model.
[0034] experimental method:
[0035] 1. Establishment of the model: After the animals adapt to the environment for 1 week, they are randomly divided into a model group and a normal group, with 30 animals in each group. Fructose rat model modeling: drinking water was given 10% fructose solution; the normal group was given tap water, the modeling cycle was 70 days.
[0036] 2. Four weeks late
Example Embodiment
[0048] Example 2: Polydatin improves the treatment of glomerulopathy in rats with glomerulosclerosis induced by adriamycin.
[0049] Experimental animals: SD rats, 200-220 grams, male.
[0050] Medicine preparation: use polydatin content of 20mg / tablet for the prevention or treatment of glomerular diseases, ultrasonically dispersed in normal saline, for intragastric administration, the dosage is 75mg / kg. Doxorubicin hydrochloride for injection (trade name: Famaxin Injection; Sufamaxia Company).
[0051] Experimental method: Focal segmental glomerulosclerosis is a common primary glomerular disease, mainly due to abnormal glomerular hemodynamics leading to podocyte damage, which is easy to progress to end-stage chronic renal failure .
[0052] 1. Establishment of the model: After the animals adapt to the environment for 1 week, they are randomly divided into a model group and a normal group, with 30 animals in each group. Rats in the model group were injected with adriamycin 2.5 mg /
Example Embodiment
[0062] Example 3:
[0063] According to the conventional preparation method, polydatin is added with water and an appropriate amount of solubilizer (polyethylene glycol 400) to dissolve, subpackage, and sterilize to prepare an oral solution for the prevention and treatment of chronic glomerular diseases with a 20mg / ml polydatin content ;
[0064] According to the conventional preparation method, polydatin and sorbitol are selected as soft capsule materials to prepare a capsule for the prevention and treatment of chronic glomerular disease with a content of 20mg / capsule of polydatin;
[0065] According to the conventional preparation method, the polydatin is added with the excipient cyclodextrin, mixed uniformly, granulated, and tableted to prepare a tablet for the prevention and treatment of chronic glomerular diseases with a content of 20 mg / tablet of polydatin.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap